Liothyronine Sodium

   
Google
 
Web NewDrugInformation.com

Liothyronine Sodium


Drug - Liothyronine Sodium
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Liothyronine Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 0.025MG BASE
The potency of the active ingredient(s), Liothyronine Sodium. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Liothyronine Sodium. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 085755
The FDA assigned number to Liothyronine Sodium. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Liothyronine Sodium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 25, 1982
The date Liothyronine Sodium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Liothyronine Sodium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Liothyronine Sodium is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Liothyronine Sodium.

Liothyronine Sodium